» Articles » PMID: 34862487

Clinical Risk Factors for Mortality in an Analysis of 1375 Patients Admitted for COVID Treatment

Overview
Journal Sci Rep
Specialty Science
Date 2021 Dec 4
PMID 34862487
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of the present work was to examine clinical risk factors for mortality in 1375 COVID + patients admitted to a hospital in Suffolk County, NY. Data were collated by the hospital epidemiological service for patients admitted from 3/7/2020 to 9/1/2020. Time until final discharge or death was the outcome. Cox proportional hazards models were used to estimate time until death among admitted patients. In total, all cases had resolved leading to 207 deaths. Length of stay was significantly longer in those who died as compared to those who did not (p = 0.007). Of patients who had been discharged, 54 were readmitted and nine subsequently died. Multivariable-adjusted Cox proportional hazards regression revealed that in addition to older age, male sex, and a history of chronic heart failure, chronic obstructive pulmonary disease, and diabetes, that a history of premorbid depression was a risk factors for COVID-19 mortality (aHR = 2.42 [1.38-4.23] P = 0.002), and that this association remained after adjusting for age and for neuropsychiatric conditions as well as medical comorbidities including cardiovascular disease and pulmonary conditions. Sex-stratified analyses revealed that associations between mortality and depression was strongest in males (aHR = 4.45 [2.04-9.72], P < 0.001), and that the association between heart failure and mortality was strongest in participants aged < 65 years old (aHR = 30.50 [9.17-101.48], P < 0.001). While an increasing number of studies have identified several comorbid medical conditions including chronic heart failure and age of patient as risk factors for mortality in COVID + patients, this study confirmed several prior reports and also noted that a history of depression is an independent risk factor for COVID-19 mortality.

Citing Articles

COVID-19 monitoring of school personnel through molecular salivary test and dried blood spot analysis.

Henin D, Fappani C, Carmagnola D, Gori M, Pellegrini G, Colzani D J Glob Health. 2024; 14:05004.

PMID: 38330189 PMC: 10852534. DOI: 10.7189/jogh.14.05004.


COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses.

Molero P, Reina G, Blom J, Martinez-Gonzalez M, Reinken A, de Kloet E Epidemiol Psychiatr Sci. 2023; 32:e61.

PMID: 37859501 PMC: 10594644. DOI: 10.1017/S2045796023000719.


Risk and predictors of severity and mortality in patients with type 2 diabetes and COVID-19 in Dubai.

Alawadi F, Bashier A, Bin Hussain A, Al-Hashmi N, Bachet F, Hassanein M World J Diabetes. 2023; 14(8):1259-1270.

PMID: 37664471 PMC: 10473944. DOI: 10.4239/wjd.v14.i8.1259.


A comprehensive study of Ecuadorian adult patients with a mild and moderate presentation of COViD-19.

Gonzalez-Andrade F, Carrero Y PLoS One. 2023; 18(3):e0283535.

PMID: 36952549 PMC: 10035819. DOI: 10.1371/journal.pone.0283535.


Ventilator avoidance among critically ill COVID-19 patients with acute respiratory distress syndrome.

Fletcher J, Aughenbaugh A, Svabek C, Hahn P, Grifka R J Int Med Res. 2022; 50(11):3000605221135446.

PMID: 36324277 PMC: 9634208. DOI: 10.1177/03000605221135446.


References
1.
Walker A, Kavelaars A, Heijnen C, Dantzer R . Neuroinflammation and comorbidity of pain and depression. Pharmacol Rev. 2013; 66(1):80-101. PMC: 3880465. DOI: 10.1124/pr.113.008144. View

2.
Glaser R, Robles T, Sheridan J, Malarkey W, Kiecolt-Glaser J . Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry. 2003; 60(10):1009-14. DOI: 10.1001/archpsyc.60.10.1009. View

3.
Trump S, Lukassen S, Anker M, Chua R, Liebig J, Thurmann L . Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol. 2020; 39(6):705-716. DOI: 10.1038/s41587-020-00796-1. View

4.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

5.
Shah H, Khan M, Dhurandhar N, Hegde V . The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19. Acta Diabetol. 2021; 58(7):831-843. PMC: 7882857. DOI: 10.1007/s00592-020-01636-z. View